Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses

Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells

(2015) Katherine Y. King et al.   EXPERIMENTAL HEMATOLOGY

TNF-α-induced programmed cell death in the pathogenesis of acquired aplastic anemia

(2015) Yongfeng Chen et al.   Expert Review of Hematology

Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications

(2014) Emmanuel Pourcelot et al.   EXPERIMENTAL HEMATOLOGY

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis

(2012) Rakhee Vaidya et al.   AMERICAN JOURNAL OF HEMATOLOGY

Genetics of IL28B and HCV—response to infection and treatment

(2012) C. Nelson Hayes et al.   Nature Reviews Gastroenterology & Hepatology

TNF  facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms

(2011) A. G. Fleischman et al.   BLOOD

Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation

(2009) Hana Bruchova et al.   BLOOD CELLS MOLECULES AND DISEASES

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

(2009) Alfonso Quintás-Cardama et al.   JOURNAL OF CLINICAL ONCOLOGY

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

(2008) J.-J. Kiladjian et al.   BLOOD

Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens

(2008) Alison R. Moliterno et al.   EXPERIMENTAL HEMATOLOGY